Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Shah Rajeev M.
Relationship:   Director, 10% Owner
City:   Boston
State:   MA
   
Insider Summary:
  
   
Companies Owned :   54    
Direct Shares   20,000    

Indirect Shares

   317,725,121      
Direct Value   $92,400    

Indirect Value

   $1,764,094,354      
Total Shares   317,745,121      
Total Value   $1,764,186,754      


Kala Pharmaceuticals, Inc. $92,400 Kala Pharmaceuticals, Inc. $92,400
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    25   
    1    

     Stock price went up :
    15   
    1    
     Stock price went down :
    10   
    0    
   
     Gain/Loss Ratio :
   1.5   
   1.0   
     Percentage Gain/Loss :
   25.6%
 20.4%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Ra Pharmaceuticals, Inc. RARX Director, 10% Owner 2016-10-31 0 2020-04-02 0    Premium*  
            Kalvista Pharmaceuticals Inc KALV Director, 10% Owner 2016-11-21 0 2017-10-12 1,441,070    Premium*  
            Kala Pharmaceuticals, Inc. KALA 10% Owner 2021-06-17 20,000 2022-05-26 7,039,613    Premium*  
            Solid Biosciences Inc SLDB Director, 10% Owner 2018-01-30 0 2022-12-02 109,661    Premium*  
            Eidos Therapeutics, Inc. EIDX Director 2018-06-22 0 2018-06-22 2,162,671    Premium*  
            Satsuma Pharmaceuticals, Inc. STSA Director, 10% Owner 2019-09-17 0 2023-06-06 0    Premium*  
            Phathom Pharmaceuticals, Inc. PHAT 10% Owner 0 2021-03-11 3,115,008    Premium*  
            89bio, Inc. ETNB Director, 10% Owner 2019-11-11 0 2025-01-30 19,889,683    Premium*  
            Synthorx, Inc. THOR 10% Owner 2020-01-23 0 2020-01-23 0    Premium*  
            Black Diamond Therapeutics, Inc. BDTX Director 2021-05-20 0 2023-07-05 3,525,754    Premium*  
            Scpharmaceuticals Inc. SCPH 10% Owner 2020-02-14 0 2021-03-15 2,727,446    Premium*  
            Verastem, Inc. VSTM 10% Owner 0 2020-06-25 16,142,051    Premium*  
            Enliven Therapeutics Ord Shs ELVN Former 10% owner 2020-03-16 0 2023-02-23 2,122,465    Premium*  
            TG Therapeutics Inc TGTX 10% Owner 0 2020-09-09 12,629,868    Premium*  
            Vaxcyte, Inc. PCVX 10% Owner 0 2020-10-08 5,001,593    Premium*  
            Forma Therapeutics Holdings, Inc., FMTX 10% Owner 2020-06-23 0 2022-10-14 0    Premium*  
            Rhythm Pharmaceuticals, Inc. RYTM 10% Owner 2020-06-25 0 2020-07-02 5,140,408    Premium*  
            Akouos, Inc. AKUS 10% Owner 2020-06-30 0 2020-06-30 2,281,249    Premium*  
            Nkarta, Inc. NKTX Director, 10% Owner 2020-07-14 0 2024-03-27 10,805,129    Premium*  
            Pandion Therapeutics, Inc. PAND 10% Owner 2020-07-21 0 2020-07-21 1,770,023    Premium*  
            Inozyme Pharma, Inc. INZY 10% Owner 2020-07-28 0 2020-07-28 2,003,653    Premium*  
            Iteos Therapeutics, Inc. ITOS Former 10% Owner 2020-07-28 0 2024-05-12 3,517,259    Premium*  
            Dyne Therapeutics, Inc. DYN 10% Owner 2020-09-21 0 2020-09-21 2,805,045    Premium*  
            Pmv Pharmaceuticals, Inc. PMVP 10% Owner 2020-09-29 0 2020-09-29 1,710,265    Premium*  
            Cardiff Oncology Inc CRDF 10% Owner 0 2020-09-30 3,290,000    Premium*  
            Orchard Therapeutics Plc ORTX 10% Owner 2020-08-10 0 2020-09-24 9,880,865    Premium*  
            Viridian Therapeutics Ors Shs VRDN 10% Owner 0 2020-12-07 410,686    Premium*  
            Iterum Therapeutics Plc ITRM 10% Owner 2021-02-04 0 2021-02-04 11,651,597    Premium*  
            Vor Biopharma Inc. VOR Director, 10% Owner 2021-02-09 0 2024-12-30 39,646,039    Premium*  
            Werewolf Therapeutics, Inc. HOWL Director, 10% Owner 2021-05-04 0 2025-05-14 6,681,307    Premium*  
            Jade Biosciences JBIO 10% Owner 2021-07-02 0 2025-04-28 1,324,954    Premium*  
            Acumen Pharmaceuticals, Inc. ABOS Director, 10% Owner 2021-07-06 0 2025-06-04 14,944,863    Premium*  
            Cytek Biosciences, Inc. CTKB Director, 10% Owner 2021-07-27 0 2022-03-15 13,381,054    Premium*  
            Icosavax, Inc. ICVX Director, 10% Owner 2021-08-02 0 2024-02-19 0    Premium*  
            Eliem Therapeutics, Inc. ELYM Director, 10% Owner 0 2024-06-27 5,417,638    Premium*  
            Rxsight, Inc. RXST 10% Owner 0 2021-08-03 3,052,796    Premium*  
            Tyra Biosciences, Inc. TYRA Director, 10% Owner 2021-09-17 0 2025-06-16 12,198,625    Premium*  
            Dice Therapeutics, Inc. DICE Former 10% owners and ... 2021-09-17 0 2023-08-09 0    Premium*  
            An2 Therapeutics Ord Shs ANTX 10% Owner 2022-03-29 0 2024-08-09 300,853    Premium*  
            Pepgen Inc. PEPG Director, 10% Owner 2022-05-10 0 2024-02-09 10,689,545    Premium*  
            Wave Life Sciences Ltd. WVE Director, 10% Owner 2022-06-16 0 2024-08-12 18,218,124    Premium*  
            Fulcrum Therapeutics, Inc. FULC 10% Owner 0 2024-09-12 10,229,099    Premium*  
            Silverback Therapeutics, Inc. SBTX Director, 10% Owner 2022-11-08 0 2024-03-27 10,860,977    Premium*  
            Acrivon Therapeutics, Inc. ACRV Director, 10% Owner 2022-11-17 0 2024-04-11 8,340,508    Premium*  
            Mineralys Therapeutics, Inc. MLYS Director 2023-02-14 0 2025-03-13 6,147,280    Premium*  
            Janux Therapeutics, Inc. JANX Director, 10% Owner 2023-07-19 0 2025-06-11 11,195,943    Premium*  
            Lenz Therapeutics LENZ Director, 10% Owner 2024-03-21 0 2024-03-21 694,755    Premium*  
            Boundless Bio, Inc. BOLD 10% Owner 2024-04-02 0 2024-04-02 295,844    Premium*  
            Cidara Therapeutics, Inc. CDTX Director 2024-07-19 0 2024-11-26 1,092,796    Premium*  
            Artiva Biotherapeutics, Inc. ARTV Director, 10% Owner 2024-07-22 0 2024-07-22 826,832    Premium*  
            Bicara Therapeutics Inc. BCAX Director, 10% Owner 2024-09-16 0 2024-09-16 2,652,575    Premium*  
            Septerna, Inc. SEPN Director, 10% Owner 2024-10-28 0 2024-10-28 1,471,943    Premium*  
            4d Molecular Therapeutics Inc. FDMT 10% Owner 0 2024-12-09 4,563,211    Premium*  
            Sionna Therapeutics, Inc. SION Director, 10% Owner 0 2025-02-10 2,324,498    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
TYRA Tyra Biosciences, Inc. Director   –       •       •   2025-06-16 4 B $10.13 $119,666 I/I 11,813 10,259,291 2.25 -
TYRA Tyra Biosciences, Inc. Director   –       •       •   2025-06-13 4 B $10.20 $1,225,703 I/I 120,167 10,247,478 2.25 -
TYRA Tyra Biosciences, Inc. Director   –       •       •   2025-06-12 4 B $10.20 $319,331 I/I 31,307 10,127,311 2.25 -
JANX Janux Therapeutics, Inc. Director   –       •       •   2025-06-11 4 A $0.00 $0 I/I 3,750 6,250 0 -
TYRA Tyra Biosciences, Inc. Director   –       •       •   2025-06-09 4 B $10.19 $1,904,002 I/I 186,850 10,096,004 2.25 -
TYRA Tyra Biosciences, Inc. Director   –       •       •   2025-06-05 4 B $10.04 $2,141,873 I/I 213,334 9,909,154 2.25 -
TYRA Tyra Biosciences, Inc. Director   –       •       •   2025-06-04 4 B $9.63 $9,609,430 I/I 997,864 9,695,820 2.25 -
ABOS Acumen Pharmaceuticals, I... Director   –       •       •   2025-06-04 4 A $0.00 $0 I/I 12,800 12,800 0 -
HOWL Werewolf Therapeutics, In... Director   –       •       •   2025-05-14 4 B $0.98 $159,288 I/I 162,539 6,237,482 2.25 -
HOWL Werewolf Therapeutics, In... Director   –       •       •   2025-05-13 4 B $0.98 $51,915 I/I 52,974 6,074,943 2.25 -
HOWL Werewolf Therapeutics, In... Director   –       •       •   2025-05-12 4 B $0.86 $275,985 I/I 320,913 6,021,969 2.25 -
JBIO Jade Biosciences 10% Owner   –       –       •   2025-04-28 4 A $0.00 $0 I/I 1,062,326 1,287,858 0 -
MLYS Mineralys Therapeutics, I... Director   –       •      –    2025-03-13 4 B $13.50 $17,499,996 I/I 1,296,296 4,280,051 2.1 -
JANX Janux Therapeutics, Inc. Director   –       •       •   2025-03-07 4 B $31.02 $3,418,590 I/I 110,206 10,141,287 2.25 -
JANX Janux Therapeutics, Inc. Director   –       •       •   2025-03-06 4 B $30.78 $11,453,023 I/I 372,093 10,031,081 2.25 -
JANX Janux Therapeutics, Inc. Director   –       •       •   2025-03-05 4 B $30.56 $10,471,352 I/I 341,742 9,658,988 2.25 -
SION Sionna Therapeutics, Inc. Director   –       •       •   2025-02-10 4 B $18.00 $20,250,000 I/I 1,125,000 2,324,498 2.25 -
SION Sionna Therapeutics, Inc. Director   –       •       •   2025-02-10 4 A $0.00 $0 I/I 7,951,493 327,808 0 -
SION Sionna Therapeutics, Inc. Director   –       •       •   2025-02-06 3 IO $0.00 $0 I/I 0 1,368,829 -
ETNB 89bio, Inc. Director   –       •       •   2025-01-30 4 B $8.75 $49,999,994 I/I 5,714,285 19,554,319 2.25 %
VOR Vor Biopharma Inc. Director   –       •       •   2024-12-30 4 A $0.00 $0 I/I 16,897,159 37,820,713 0 -
FDMT 4d Molecular Therapeutics... 10% Owner   –       –       •   2024-12-09 4 D $0.00 $0 I/I (535,000) 4,563,211 0 -
CDTX Cidara Therapeutics, Inc. Director   –       •      –    2024-11-26 4 A $14.91 $5,811,445 I/I 389,716 1,092,796 0 -
FDMT 4d Molecular Therapeutics... 10% Owner   –       –       •   2024-11-13 3 IO $0.00 $0 I/I 0 5,098,211 -
TYRA Tyra Biosciences, Inc. Director   –       •       •   2024-11-08 4 B $16.25 $19,836,066 I/I 1,220,681 8,697,956 2.25 -
  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us